Singapore

The Asian pharmaceuticals industry is currently evolving under the influence of four innovation trends, according to Richard M. Johnson, President & CEO, Parenteral Drug Association (PDA), a leading non-profit organization advising the pharmaceutical industry.

The changing demographics and evolving trends across Asia-Pacific mean that traditional operating models have become obsolete for healthcare providers. Focusing on cost efficient delivery of healthcare through shared responsibility across the value chain is called for, now more than ever.